Hostname: page-component-848d4c4894-8kt4b Total loading time: 0 Render date: 2024-06-19T07:16:28.685Z Has data issue: false hasContentIssue false

Acatisia nocturna de comienzo diferido debido a risperidona y levomepromacina: un informe clínico

Published online by Cambridge University Press:  12 May 2020

E. Shimizu
Affiliation:
Departamento de Psiquiatría (K2), Escuela de Medicina para Graduados de la Universidad de Chiba, 1-8-1 Inohana, Chuou-ku, Chiba 260-8670, Japón
H. Watanabe
Affiliation:
Departamento de Psiquiatría (K2), Escuela de Medicina para Graduados de la Universidad de Chiba, 1-8-1 Inohana, Chuou-ku, Chiba 260-8670, Japón
M. Iyo
Affiliation:
Departamento de Psiquiatría (K2), Escuela de Medicina para Graduados de la Universidad de Chiba, 1-8-1 Inohana, Chuou-ku, Chiba 260-8670, Japón
Get access

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Informe ClÍnico
Copyright
Copyright © European Psychiatric Association 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografía

1Sachdev, P. The development of the concept of akathisia: a historical overview. Schizophr Res 1995;l6(1):3345.CrossRefGoogle Scholar
2Walters, AS, Hening, W. Rubinstein, M, et al. A clinical and polysomnography comparison of neuroleptic-induced akathisia and the idiopathic restless legs syndrome. Sleep 1991;14(4):339-45.Google Scholar
3Lai, S, Nair, NP. Is levomepromazine a useful drug in treatmentresistant schizophrenia? Acta Psychiatr Scand 1992;85(3):243-5.Google Scholar
4Blaisdell, GD. Akathisia: a comprehensive review and treatment summary. Pharmacopsychiatry 1994;27(4):139-46.CrossRefGoogle ScholarPubMed
5Miller, CH, Mohr, F, Umbricht, D, et al. The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics. J Clin Psychiatry 1998;59(2):6975.CrossRefGoogle ScholarPubMed
6Meltzer, HY. The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 1999;21 (2 Suppl):106S-15S.CrossRefGoogle ScholarPubMed
7Lai, S, Nair, NP, Cecyre, D, et al. Levomepromazine receptor binding profile in human brain-implications for treatmentresistant schizophrenia. Acta Psychiatr Scand 1993;87(6):380-3.Google Scholar